Ambarella [AMBA] vs Nova [NVMI] Detailed Stock Comparison
Ambarella
NASDAQ
Loading...
Nova
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ambarella wins in 8 metrics, Nova wins in 10 metrics, with 0 ties. Nova appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ambarella | Nova | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -23.32 | 33.88 | Ambarella |
| Price-to-Book Ratio | 5.05 | 6.69 | Ambarella |
| Debt-to-Equity Ratio | 0.77 | 19.08 | Ambarella |
| PEG Ratio | 0.62 | 0.68 | Ambarella |
| EV/EBITDA | -25.93 | 27.67 | Ambarella |
| Profit Margin (TTM) | -32.73% | 29.10% | Nova |
| Operating Margin (TTM) | -30.11% | 29.84% | Nova |
| EBITDA Margin (TTM) | N/A | 29.84% | N/A |
| Return on Equity | -18.35% | 24.23% | Nova |
| Return on Assets (TTM) | -10.54% | 10.50% | Nova |
| Free Cash Flow (TTM) | $23.46M | $218.05M | Nova |
| 1-Year Return | 32.38% | 10.86% | Ambarella |
| Price-to-Sales Ratio (TTM) | 9.14 | 9.08 | Nova |
| Enterprise Value | $2.59B | $6.99B | Nova |
| EV/Revenue Ratio | 8.18 | 8.66 | Ambarella |
| Gross Profit Margin (TTM) | 60.01% | 57.84% | Ambarella |
| Revenue per Share (TTM) | $8 | $28 | Nova |
| Earnings per Share (Diluted) | $-2.49 | $7.36 | Nova |
| Beta (Stock Volatility) | 2.08 | 1.67 | Nova |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ambarella vs Nova Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ambarella | 9.04% | -3.73% | -5.35% | 3.82% | -15.58% | -10.90% |
| Nova | 2.42% | -8.72% | -13.23% | 34.21% | -8.04% | 21.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ambarella | 32.38% | -21.70% | 26.94% | -31.45% | 959.71% | 959.71% |
| Nova | 10.86% | 135.13% | 359.18% | 2,133.24% | 5,050.42% | 9,482.17% |
Performance & Financial Health Analysis: Ambarella vs Nova
| Metric | AMBA | NVMI |
|---|---|---|
| Market Information | ||
| Market Cap | $2.89B | $7.33B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 442,248 | 266,510 |
| 90 Day Avg. Volume | 521,106 | 269,827 |
| Last Close | $71.99 | $253.21 |
| 52 Week Range | $38.86 - $85.15 | $154.00 - $291.99 |
| % from 52W High | -15.46% | -13.28% |
| All-Time High | $227.59 (Nov 29, 2021) | $291.99 (Jul 07, 2025) |
| % from All-Time High | -68.37% | -13.28% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.58% | 0.40% |
| Quarterly Earnings Growth | 0.58% | 0.51% |
| Financial Health | ||
| Profit Margin (TTM) | -0.33% | 0.29% |
| Operating Margin (TTM) | -0.30% | 0.30% |
| Return on Equity (TTM) | -0.18% | 0.24% |
| Debt to Equity (MRQ) | 0.77 | 19.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.50 | $37.27 |
| Cash per Share (MRQ) | $6.12 | $18.92 |
| Operating Cash Flow (TTM) | $63.59M | $229.71M |
| Levered Free Cash Flow (TTM) | $90.96M | $139.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ambarella vs Nova
| Metric | AMBA | NVMI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -23.32 | 33.88 |
| Forward P/E | -378.67 | 33.07 |
| PEG Ratio | 0.62 | 0.68 |
| Price to Sales (TTM) | 9.14 | 9.08 |
| Price to Book (MRQ) | 5.05 | 6.69 |
| Market Capitalization | ||
| Market Capitalization | $2.89B | $7.33B |
| Enterprise Value | $2.59B | $6.99B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.18 | 8.66 |
| Enterprise to EBITDA | -25.93 | 27.67 |
| Risk & Other Metrics | ||
| Beta | 2.08 | 1.67 |
| Book Value per Share (MRQ) | $13.50 | $37.27 |
Financial Statements Comparison: Ambarella vs Nova
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMBA | NVMI |
|---|---|---|
| Revenue/Sales | $85.87M | $213.36M |
| Cost of Goods Sold | $34.34M | $91.05M |
| Gross Profit | $51.54M | $122.30M |
| Research & Development | $58.82M | $33.23M |
| Operating Income (EBIT) | $-25.86M | $63.23M |
| EBITDA | $-19.11M | $68.13M |
| Pre-Tax Income | $-23.68M | $76.17M |
| Income Tax | $645,000 | $11.35M |
| Net Income (Profit) | $-24.33M | $64.82M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMBA | NVMI |
|---|---|---|
| Cash & Equivalents | $141.29M | $141.06M |
| Total Current Assets | $335.55M | $875.74M |
| Total Current Liabilities | $124.85M | $401.78M |
| Long-Term Debt | $2.06M | $47.66M |
| Total Shareholders Equity | $572.72M | $982.12M |
| Retained Earnings | $-276.39M | N/A |
| Property, Plant & Equipment | $13.06M | $139.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMBA | NVMI |
|---|---|---|
| Operating Cash Flow | $15.43M | $73.99M |
| Capital Expenditures | $-4.57M | $-8.86M |
| Free Cash Flow | $10.24M | $59.69M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-1.00M | $-20.00M |
Short Interest & Institutional Ownership Analysis
| Metric | AMBA | NVMI |
|---|---|---|
| Shares Short | 2.17M | 1.48M |
| Short Ratio | 3.58 | 5.04 |
| Short % of Float | 0.06% | 0.05% |
| Average Daily Volume (10 Day) | 442,248 | 266,510 |
| Average Daily Volume (90 Day) | 521,106 | 269,827 |
| Shares Outstanding | 41.96M | 29.28M |
| Float Shares | 39.87M | 29.38M |
| % Held by Insiders | 0.05% | 0.00% |
| % Held by Institutions | 0.89% | 0.77% |
Dividend Analysis & Yield Comparison: Ambarella vs Nova
| Metric | AMBA | NVMI |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |